Skip to main content

Closed

KYTX: Kyverna Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-71.4%

Financially safe

Stretched

Debt / equity0.17×

Interest coverage-144.7×

Current ratio8.15×

Kyverna Therapeutics, Inc.

KYTXNASDAQ·USD·Closed

Kyverna Therapeutics, Inc.

KYTXNASDAQ·USD·Closed

$7.30

−2.54%

$7.30

−$0.19 (2.54%)

52W Range

41thpctl

Volume

0.50×avg

Mkt Cap

443.81MUSD

P/E

-2.2TTM

Div Yield

–ann

52W Range

41thpctl

Volume

0.50×avg

Market Cap

443.81MUSD

P/E Ratio

-2.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings